Report for Fernandez AP

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease - Serrano_2017_J.Psychiatry.Neurosci_42_59
Author(s) : Serrano MP , Herrero-Labrador R , Futch HS , Serrano J , Romero A , Fernandez AP , Samadi A , Unzeta M , Marco-Contelles J , Martinez-Murillo R
Ref : J Psychiatry Neurosci , 42 :59 , 2017
Abstract : Serrano_2017_J.Psychiatry.Neurosci_42_59
ESTHER : Serrano_2017_J.Psychiatry.Neurosci_42_59
PubMedSearch : Serrano_2017_J.Psychiatry.Neurosci_42_59
PubMedID: 27636528

Title : Nitric oxide: target for therapeutic strategies in Alzheimer's disease - Fernandez_2010_Curr.Pharm.Des_16_2837
Author(s) : Fernandez AP , Pozo-Rodrigalvarez A , Serrano J , Martinez-Murillo R
Ref : Curr Pharm Des , 16 :2837 , 2010
Abstract : Fernandez_2010_Curr.Pharm.Des_16_2837
ESTHER : Fernandez_2010_Curr.Pharm.Des_16_2837
PubMedSearch : Fernandez_2010_Curr.Pharm.Des_16_2837
PubMedID: 20698819